| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |